{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:55:46Z","timestamp":1791410146274,"version":"4.3.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH","award":["UC4DK116284"],"award-info":[{"award-number":["UC4DK116284"]}]},{"name":"Breakthrough T1D","award":["2-SRA-2018-551-S-B"],"award-info":[{"award-number":["2-SRA-2018-551-S-B"]}]},{"name":"Breakthrough T1D","award":["3-SRA-2023-1417-S-B"],"award-info":[{"award-number":["3-SRA-2023-1417-S-B"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00125-025-06458-8","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T18:18:43Z","timestamp":1749493123000},"page":"1721-1734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["T cell and autoantibody recognition of nucleus-associated islet autoantigens in individuals with type 1 diabetes"],"prefix":"10.1007","volume":"68","author":[{"given":"Perrin","family":"Guyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapitolina","family":"Seminova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Lugar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Manganaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6985-8441","authenticated-orcid":false,"given":"Erandi E.","family":"Velarde de la Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1005-0621","authenticated-orcid":false,"given":"Megan E.","family":"Smithmyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1480-4272","authenticated-orcid":false,"given":"Cate","family":"Speake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8704-4713","authenticated-orcid":false,"given":"Ezio","family":"Bonifacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1543-8086","authenticated-orcid":false,"given":"Sally C.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7217-5729","authenticated-orcid":false,"given":"Eddie A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"issue":"4","key":"6458_CR1","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2337\/db07-1331","volume":"57","author":"H Erlich","year":"2008","unstructured":"Erlich H, Valdes AM, Noble J et al (2008) HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 57(4):1084\u20131092. https:\/\/doi.org\/10.2337\/db07-1331","journal-title":"Diabetes"},{"key":"6458_CR2","doi-asserted-by":"publisher","first-page":"6581213","DOI":"10.1155\/2021\/6581213","volume":"2021","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Deng C, Zhou Z (2021) The multiple roles of B lymphocytes in the onset and treatment of type 1 diabetes: interactions between B lymphocytes and T cells. J Diabetes Res 2021:6581213. https:\/\/doi.org\/10.1155\/2021\/6581213","journal-title":"J Diabetes Res"},{"issue":"4","key":"6458_CR3","doi-asserted-by":"publisher","first-page":"a007781","DOI":"10.1101\/cshperspect.a007781","volume":"2","author":"BO Roep","year":"2012","unstructured":"Roep BO, Peakman M (2012) Antigen targets of type 1 diabetes autoimmunity. Cold Spring Harb Perspect Med 2(4):a007781. https:\/\/doi.org\/10.1101\/cshperspect.a007781","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"Suppl 2","key":"6458_CR4","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.2337\/diabetes.54.suppl_2.s52","volume":"54","author":"C Pihoker","year":"2005","unstructured":"Pihoker C, Gilliam LK, Hampe CS, Lernmark A (2005) Autoantibodies in diabetes. Diabetes 54(Suppl 2):S52\u2013S61. https:\/\/doi.org\/10.2337\/diabetes.54.suppl_2.s52","journal-title":"Diabetes"},{"issue":"10","key":"6458_CR5","doi-asserted-by":"publisher","first-page":"6056","DOI":"10.4049\/jimmunol.1003815","volume":"186","author":"M Dang","year":"2011","unstructured":"Dang M, Rockell J, Wagner R et al (2011) Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8. J Immunol 186(10):6056\u20136063. https:\/\/doi.org\/10.4049\/jimmunol.1003815","journal-title":"J Immunol"},{"issue":"1","key":"6458_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2006.03244.x","volume":"148","author":"TP Di Lorenzo","year":"2007","unstructured":"Di Lorenzo TP, Peakman M, Roep BO (2007) Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes. Clin Exp Immunol 148(1):1\u201316. https:\/\/doi.org\/10.1111\/j.1365-2249.2006.03244.x","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"6458_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00125-003-1089-5","volume":"46","author":"BO Roep","year":"2003","unstructured":"Roep BO (2003) The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure. Diabetologia 46(3):305\u2013321. https:\/\/doi.org\/10.1007\/s00125-003-1089-5","journal-title":"Diabetologia"},{"issue":"5","key":"6458_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.tem.2021.02.001","volume":"32","author":"SK Patel","year":"2021","unstructured":"Patel SK, Ma CS, Fourlanos S, Greenfield JR (2021) Autoantibody-negative type 1 diabetes: a neglected subtype. Trends Endocrinol Metab 32(5):295\u2013305. https:\/\/doi.org\/10.1016\/j.tem.2021.02.001","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"6458_CR9","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2337\/dbi18-0066","volume":"68","author":"AW Purcell","year":"2019","unstructured":"Purcell AW, Sechi S, DiLorenzo TP (2019) The evolving landscape of autoantigen discovery and characterization in type 1 diabetes. Diabetes 68(5):879\u2013886. https:\/\/doi.org\/10.2337\/dbi18-0066","journal-title":"Diabetes"},{"key":"6458_CR10","doi-asserted-by":"publisher","first-page":"622647","DOI":"10.3389\/fendo.2021.622647","volume":"12","author":"LG Landry","year":"2021","unstructured":"Landry LG, Anderson AM, Russ HA et al (2021) Proinsulin-reactive CD4 T cells in the islets of type 1 diabetes organ donors. Front Endocrinol (Lausanne) 12:622647. https:\/\/doi.org\/10.3389\/fendo.2021.622647","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"6458_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1021\/acs.jproteome.6b00354","volume":"16","author":"X Bian","year":"2017","unstructured":"Bian X, Wasserfall C, Wallstrom G et al (2017) Tracking the antibody immunome in type 1 diabetes using protein arrays. J Proteome Res 16(1):195\u2013203. https:\/\/doi.org\/10.1021\/acs.jproteome.6b00354","journal-title":"J Proteome Res"},{"key":"6458_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.clim.2018.07.001","volume":"194","author":"D M\u00fcller","year":"2018","unstructured":"M\u00fcller D, Telieps T, Eugster A et al (2018) Novel minor HLA DR associated antigens in type 1 diabetes. Clin Immunol 194:87\u201391. https:\/\/doi.org\/10.1016\/j.clim.2018.07.001","journal-title":"Clin Immunol"},{"issue":"23","key":"6458_CR13","doi-asserted-by":"publisher","first-page":"e108788","DOI":"10.15252\/embj.2021108788","volume":"40","author":"G Holzer","year":"2021","unstructured":"Holzer G, De Magistris P, Gramminger C et al (2021) The nucleoporin Nup50 activates the Ran guanine nucleotide exchange factor RCC1 to promote NPC assembly at the end of mitosis. EMBO J 40(23):e108788. https:\/\/doi.org\/10.15252\/embj.2021108788","journal-title":"EMBO J"},{"issue":"18","key":"6458_CR14","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1093\/nar\/gkh855","volume":"32","author":"AR Ellison","year":"2004","unstructured":"Ellison AR, Lofing J, Bitter GA (2004) Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain. Nucleic Acids Res 32(18):5321\u20135338. https:\/\/doi.org\/10.1093\/nar\/gkh855","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"6458_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11892-011-0223-x","volume":"11","author":"JA Noble","year":"2011","unstructured":"Noble JA, Valdes AM (2011) Genetics of the HLA region in the prediction of type 1 diabetes. Curr Diab Rep 11(6):533\u2013542. https:\/\/doi.org\/10.1007\/s11892-011-0223-x","journal-title":"Curr Diab Rep"},{"issue":"1","key":"6458_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2337\/db22-0191","volume":"72","author":"P Guyer","year":"2023","unstructured":"Guyer P, Arribas-Layton D, Manganaro A et al (2023) Recognition of mRNA splice variant and secretory granule epitopes by CD4+ T cells in type 1 diabetes. Diabetes 72(1):85\u201396. https:\/\/doi.org\/10.2337\/db22-0191","journal-title":"Diabetes"},{"issue":"7","key":"6458_CR17","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/art.38637","volume":"66","author":"EA James","year":"2014","unstructured":"James EA, Rieck M, Pieper J et al (2014) Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy. Arthritis Rheumatol (Hoboken, NJ) 66(7):1712\u20131722. https:\/\/doi.org\/10.1002\/art.38637","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"12","key":"6458_CR18","doi-asserted-by":"publisher","first-page":"R63","DOI":"10.1172\/jci8476","volume":"104","author":"EJ Novak","year":"1999","unstructured":"Novak EJ, Liu AW, Nepom GT, Kwok WW (1999) MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. J Clin Investig 104(12):R63\u2013R67. https:\/\/doi.org\/10.1172\/jci8476","journal-title":"J Clin Investig"},{"key":"6458_CR19","doi-asserted-by":"publisher","first-page":"12614","DOI":"10.1038\/ncomms12614","volume":"7","author":"H Uchtenhagen","year":"2016","unstructured":"Uchtenhagen H, Rims C, Blahnik G et al (2016) Efficient ex vivo analysis of CD4+ T-cell responses using combinatorial HLA class II tetramer staining. Nat Commun 7:12614. https:\/\/doi.org\/10.1038\/ncomms12614","journal-title":"Nat Commun"},{"issue":"5","key":"6458_CR20","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.4049\/jimmunol.0802228","volume":"183","author":"EA James","year":"2009","unstructured":"James EA, Moustakas AK, Bui J, Nouv R, Papadopoulos GK, Kwok WW (2009) The binding of antigenic peptides to HLA-DR is influenced by interactions between pocket 6 and pocket 9. J Immunol 183(5):3249\u20133258. https:\/\/doi.org\/10.4049\/jimmunol.0802228","journal-title":"J Immunol"},{"issue":"6","key":"6458_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/bf00284452","volume":"25","author":"SE Fineberg","year":"1983","unstructured":"Fineberg SE, Galloway JA, Fineberg NS, Rathbun MJ, Hufferd S (1983) Immunogenicity of recombinant DNA human insulin. Diabetologia 25(6):465\u2013469. https:\/\/doi.org\/10.1007\/bf00284452","journal-title":"Diabetologia"},{"issue":"12","key":"6458_CR22","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1038\/nm.4203","volume":"22","author":"JA Babon","year":"2016","unstructured":"Babon JA, DeNicola ME, Blodgett DM et al (2016) Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes. Nat Med 22(12):1482\u20131487. https:\/\/doi.org\/10.1038\/nm.4203","journal-title":"Nat Med"},{"key":"6458_CR23","doi-asserted-by":"publisher","unstructured":"Carr\u00e9 A, Zhou Z, Perez-Hernandez J et al (2023) Interferon-\u03b1 promotes neo-antigen formation and preferential HLA-B-restricted antigen presentation in pancreatic \u03b2-cells. bioRxiv\u00a02023.09.15.557918 (Preprint). Available from:\u00a0https:\/\/doi.org\/10.1101\/2023.09.15.557918","DOI":"10.1101\/2023.09.15.557918"},{"issue":"9","key":"6458_CR24","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s00125-016-3997-1","volume":"59","author":"D Walther","year":"2016","unstructured":"Walther D, Eugster A, Jergens S et al (2016) Tetraspanin 7 autoantibodies in type 1 diabetes. Diabetologia 59(9):1973\u20131976. https:\/\/doi.org\/10.1007\/s00125-016-3997-1","journal-title":"Diabetologia"},{"issue":"9","key":"6458_CR25","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.2337\/dc19-2547","volume":"43","author":"K Vehik","year":"2020","unstructured":"Vehik K, Bonifacio E, Lernmark \u00c5 et al (2020) Hierarchical order of distinct autoantibody spreading and progression to type 1 diabetes in the TEDDY study. Diabetes Care 43(9):2066\u20132073. https:\/\/doi.org\/10.2337\/dc19-2547","journal-title":"Diabetes Care"},{"issue":"3","key":"6458_CR26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2337\/db09-1378","volume":"59","author":"E Ferrannini","year":"2010","unstructured":"Ferrannini E, Mari A, Nofrate V, Sosenko JM, Skyler JS (2010) Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset. Diabetes 59(3):679\u2013685. https:\/\/doi.org\/10.2337\/db09-1378","journal-title":"Diabetes"},{"issue":"23","key":"6458_CR27","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1001\/jama.2013.6285","volume":"309","author":"AG Ziegler","year":"2013","unstructured":"Ziegler AG, Rewers M, Simell O et al (2013) Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309(23):2473\u20132479. https:\/\/doi.org\/10.1001\/jama.2013.6285","journal-title":"JAMA"},{"issue":"4","key":"6458_CR28","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.4049\/jimmunol.176.4.2654","volume":"176","author":"J Tian","year":"2006","unstructured":"Tian J, Zekzer D, Lu Y, Dang H, Kaufman DL (2006) B cells are crucial for determinant spreading of T cell autoimmunity among \u03b2 cell antigens in diabetes-prone nonobese diabetic mice. J Immunol 176(4):2654\u20132661. https:\/\/doi.org\/10.4049\/jimmunol.176.4.2654","journal-title":"J Immunol"},{"key":"6458_CR29","doi-asserted-by":"publisher","first-page":"675746","DOI":"10.3389\/fimmu.2021.675746","volume":"12","author":"S Arif","year":"2021","unstructured":"Arif S, Pujol-Autonell I, Kamra Y et al (2021) Mapping T cell responses to native and neo-islet antigen epitopes in at risk and type 1 diabetes subjects. Front Immunol 12:675746. https:\/\/doi.org\/10.3389\/fimmu.2021.675746","journal-title":"Front Immunol"},{"issue":"3","key":"6458_CR30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00125-018-4760-6","volume":"62","author":"SI Mannering","year":"2019","unstructured":"Mannering SI, Di Carluccio AR, Elso CM (2019) Neoepitopes: a new take on beta cell autoimmunity in type 1 diabetes. Diabetologia 62(3):351\u2013356. https:\/\/doi.org\/10.1007\/s00125-018-4760-6","journal-title":"Diabetologia"},{"key":"6458_CR31","doi-asserted-by":"publisher","first-page":"667989","DOI":"10.3389\/fimmu.2021.667989","volume":"12","author":"T Rodriguez-Calvo","year":"2021","unstructured":"Rodriguez-Calvo T, Johnson JD, Overbergh L, Dunne JL (2021) Neoepitopes in type 1 diabetes: etiological insights, biomarkers and therapeutic targets. Front Immunol 12:667989. https:\/\/doi.org\/10.3389\/fimmu.2021.667989","journal-title":"Front Immunol"},{"issue":"7","key":"6458_CR32","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.2337\/dbi19-0022","volume":"69","author":"EA James","year":"2020","unstructured":"James EA, Mallone R, Kent SC, DiLorenzo TP (2020) T-cell epitopes and neo-epitopes in type 1 diabetes: a comprehensive update and reappraisal. Diabetes 69(7):1311\u20131335. https:\/\/doi.org\/10.2337\/dbi19-0022","journal-title":"Diabetes"},{"issue":"15","key":"6458_CR33","doi-asserted-by":"publisher","first-page":"5631","DOI":"10.1128\/mcb.20.15.5631-5642.2000","volume":"20","author":"M Smitherman","year":"2000","unstructured":"Smitherman M, Lee K, Swanger J, Kapur R, Clurman BE (2000) Characterization and targeted disruption of murine Nup50, a p27(Kip1)-interacting component of the nuclear pore complex. Mol Cell Biol 20(15):5631\u20135642. https:\/\/doi.org\/10.1128\/mcb.20.15.5631-5642.2000","journal-title":"Mol Cell Biol"},{"issue":"16","key":"6458_CR34","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1091\/mbc.E14-04-0865","volume":"25","author":"AL Buchwalter","year":"2014","unstructured":"Buchwalter AL, Liang Y, Hetzer MW (2014) Nup50 is required for cell differentiation and exhibits transcription-dependent dynamics. Mol Biol Cell 25(16):2472\u20132484. https:\/\/doi.org\/10.1091\/mbc.E14-04-0865","journal-title":"Mol Biol Cell"},{"key":"6458_CR35","doi-asserted-by":"publisher","first-page":"103178","DOI":"10.1016\/j.dnarep.2021.103178","volume":"106","author":"KS Shrestha","year":"2021","unstructured":"Shrestha KS, Aska EM, Tuominen MM, Kauppi L (2021) Tissue-specific reduction in MLH1 expression induces microsatellite instability in intestine of Mlh1(+\/-) mice. DNA Repair (Amst) 106:103178. https:\/\/doi.org\/10.1016\/j.dnarep.2021.103178","journal-title":"DNA Repair (Amst)"},{"issue":"1","key":"6458_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ccell.2020.11.004","volume":"39","author":"J Guan","year":"2021","unstructured":"Guan J, Lu C, Jin Q et al (2021) MLH1 deficiency-triggered DNA hyperexcision by exonuclease 1 activates the cGAS-STING pathway. Cancer Cell 39(1):109-121.e105. https:\/\/doi.org\/10.1016\/j.ccell.2020.11.004","journal-title":"Cancer Cell"},{"issue":"12","key":"6458_CR37","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1002\/art.38866","volume":"66","author":"Y Muro","year":"2014","unstructured":"Muro Y, Nakashima R, Hosono Y, Sugiura K, Mimori T, Akiyama M (2014) Autoantibodies to DNA mismatch repair enzymes in polymyositis\/dermatomyositis and other autoimmune diseases: a possible marker of favorable prognosis. Arthritis Rheumatol 66(12):3457\u20133462. https:\/\/doi.org\/10.1002\/art.38866","journal-title":"Arthritis Rheumatol"},{"key":"6458_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cca.2015.01.014","volume":"442","author":"Y Muro","year":"2015","unstructured":"Muro Y, Sugiura K, Mimori T, Akiyama M (2015) DNA mismatch repair enzymes: genetic defects and autoimmunity. Clin Chim Acta 442:102\u2013109. https:\/\/doi.org\/10.1016\/j.cca.2015.01.014","journal-title":"Clin Chim Acta"},{"key":"6458_CR39","doi-asserted-by":"publisher","first-page":"104729","DOI":"10.1016\/j.cellimm.2023.104729","volume":"390","author":"AK Moustakas","year":"2023","unstructured":"Moustakas AK, Nguyen H, James EA, Papadopoulos GK (2023) Autoimmune susceptible HLA class II motifs facilitate the presentation of modified neoepitopes to potentially autoreactive T cells. Cell Immunol 390:104729. https:\/\/doi.org\/10.1016\/j.cellimm.2023.104729","journal-title":"Cell Immunol"},{"issue":"10","key":"6458_CR40","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.4049\/jimmunol.172.10.5967","volume":"172","author":"NA Danke","year":"2004","unstructured":"Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW (2004) Autoreactive T cells in healthy individuals. J Immunol 172(10):5967\u20135972. https:\/\/doi.org\/10.4049\/jimmunol.172.10.5967","journal-title":"J Immunol"},{"key":"6458_CR41","doi-asserted-by":"publisher","first-page":"1015855","DOI":"10.3389\/fimmu.2022.1015855","volume":"13","author":"H Nguyen","year":"2022","unstructured":"Nguyen H, Arribas-Layton D, Chow IT et al (2022) Characterizing T cell responses to enzymatically modified beta cell neo-epitopes. Front Immunol 13:1015855. https:\/\/doi.org\/10.3389\/fimmu.2022.1015855","journal-title":"Front Immunol"},{"issue":"21","key":"6458_CR42","doi-asserted-by":"publisher","first-page":"e167881","DOI":"10.1172\/jci.insight.167881","volume":"8","author":"E Balmas","year":"2023","unstructured":"Balmas E, Chen J, Hu AK et al (2023) Islet-autoreactive CD4+ T cells are linked with response to alefacept in type 1 diabetes. JCI Insight 8(21):e167881. https:\/\/doi.org\/10.1172\/jci.insight.167881","journal-title":"JCI Insight"},{"issue":"5214","key":"6458_CR43","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1126\/science.7761837","volume":"268","author":"JD Katz","year":"1995","unstructured":"Katz JD, Benoist C, Mathis D (1995) T helper cell subsets in insulin-dependent diabetes. Science 268(5214):1185\u20131188. https:\/\/doi.org\/10.1126\/science.7761837","journal-title":"Science"},{"issue":"6","key":"6458_CR44","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.4049\/jimmunol.164.6.3072","volume":"164","author":"M Poulin","year":"2000","unstructured":"Poulin M, Haskins K (2000) Induction of diabetes in nonobese diabetic mice by Th2 T cell clones from a TCR transgenic mouse. J Immunol 164(6):3072\u20133078. https:\/\/doi.org\/10.4049\/jimmunol.164.6.3072","journal-title":"J Immunol"},{"issue":"6220","key":"6458_CR45","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM et al (2015) Proteomics. Tissue-based map of the human proteome. Science 347(6220):1260419. https:\/\/doi.org\/10.1126\/science.1260419","journal-title":"Science"},{"issue":"7","key":"6458_CR46","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2337\/db19-0058","volume":"68","author":"KH Kaestner","year":"2019","unstructured":"Kaestner KH, Powers AC, Naji A, Atkinson MA (2019) NIH initiative to improve understanding of the pancreas, islet, and autoimmunity in type 1 diabetes: the Human Pancreas Analysis Program (HPAP). Diabetes 68(7):1394\u20131402. https:\/\/doi.org\/10.2337\/db19-0058","journal-title":"Diabetes"},{"issue":"1","key":"6458_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1084\/jem.20101574","volume":"208","author":"JJ Sabatino Jr","year":"2011","unstructured":"Sabatino JJ Jr, Huang J, Zhu C, Evavold BD (2011) High prevalence of low affinity peptide-MHC II tetramer-negative effectors during polyclonal CD4+ T cell responses. J Exp Med 208(1):81\u201390. https:\/\/doi.org\/10.1084\/jem.20101574","journal-title":"J Exp Med"},{"issue":"10","key":"6458_CR48","doi-asserted-by":"publisher","first-page":"e0186998","DOI":"10.1371\/journal.pone.0186998","volume":"12","author":"S Reiss","year":"2017","unstructured":"Reiss S, Baxter AE, Cirelli KM et al (2017) Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells. PLoS One 12(10):e0186998. https:\/\/doi.org\/10.1371\/journal.pone.0186998","journal-title":"PLoS One"},{"issue":"19","key":"6458_CR49","doi-asserted-by":"publisher","first-page":"10661","DOI":"10.1128\/jvi.00056-12","volume":"86","author":"B Vingert","year":"2012","unstructured":"Vingert B, Benati D, Lambotte O et al (2012) HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term. J Virol 86(19):10661\u201310674. https:\/\/doi.org\/10.1128\/jvi.00056-12","journal-title":"J Virol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06458-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06458-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06458-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:02:47Z","timestamp":1780963367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06458-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["6458"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06458-8","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We thank T.-S. Nguyen (BRI Clinical Core) for organising and assisting with shipment of archived samples and V. Green and C. Cousens-Jacobs (BRI) for administrative support. This manuscript used data acquired from the Human Pancreas Analysis Program (HPAP-RRID:SCR_016202) Database (\n                      \n                      ), a Human Islet Research Network (RRID:SCR_014393) consortium (UC4-DK-112217, U01-DK-123594, UC4-DK-112232 and U01-DK-123716). This research was performed with the support of the Network for Pancreatic Organ Donors with Diabetes (nPOD; RRID:SCR_014641), a collaborative type 1 diabetes research project supported by Breakthrough T1D and The Leona M. & Harry B. Helmsley Charitable Trust (Grant 3-SRA-2023-1417-S-B). The content and views expressed are the responsibility of the authors and do not necessarily reflect the official view of nPOD. Organ Procurement Organizations (OPOs) partnering with nPOD to provide research resources are listed at\n                      \n                      .","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"Data are available on request from the corresponding author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Funding for this research was provided by Breakthrough T1D (formerly known as JDRF) Grant 2-SRA-2018-551-S-B to EAJ. SCK was funded by NIH-NIDDK UC4DK116284 and The George F. and Sybil H. Fuller Term Chair in Diabetes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"EAJ conceptualised and designed the study. KS and PG acquired peptide binding assay and T cell assay data and performed data analysis. ML and EB designed and executed LIPS assays to measure autoantibodies directed against NUP50 and MLH1, and analysed and interpreted the resulting data. AM and EEVC made substantial contributions to the analysis or interpretation of data and SCK made substantial contributions to the design of the work, or the acquisition, analysis, and interpretation of data, drafting the article, reviewing it critically for important intellectual content. RH, MES and CS were responsible for participant selection and collected and interpreted clinical data. EAJ wrote the manuscript with assistance and approval from all co-authors. EAJ obtained funding and was responsible for the entire project. EAJ is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}